The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| QTRX | -37.07% | -85.59% | -32.11% | -62% |
| S&P | +14.77% | +87.2% | +13.35% | +163% |
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
The market might, just might, have over-reacted to the company's dispiriting second-quarter results the previous day.
Investors gave the thumbs-down to the biotech's latest reported quarter.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $40.23M | 12.3% |
| Gross Profit | $17.21M | -14.6% |
| Gross Margin | 42.77% | -13.5% |
| Market Cap | $252.31M | -49.3% |
| Market Cap / Employee | $535.69K | 0.0% |
| Employees | 471 | 0.0% |
| Net Income | -$33,517.00K | -301.3% |
| EBITDA | -$23,512.00K | -144.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $38.30M | 30.5% |
| Accounts Receivable | $33.03M | 6.2% |
| Inventory | 55 | 66.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $31.71M | -6.3% |
| Short Term Debt | $8.41M | 81.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -22.37% | -13.9% |
| Return On Invested Capital | -13.84% | 3.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$41,926.00K | -535.4% |
| Operating Free Cash Flow | -$41,249.00K | -617.7% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.21 | 0.76 | 0.82 | 0.72 | -51.16% |
| Price to Sales | 2.98 | 1.86 | 2.06 | 1.92 | -48.42% |
| Price to Tangible Book Value | 1.22 | 0.77 | 0.88 | 0.76 | -49.04% |
| Enterprise Value to EBITDA | -12.62 | -1.08 | -1.22 | -6.61 | -73.91% |
| Return on Equity | -11.3% | -14.5% | -22.3% | -29.3% | 183.75% |
| Total Debt | $37.37M | $36.41M | $35.53M | $40.12M | 4.23% |
No podcast episodes available.
QTRX earnings call for the period ending September 30, 2021.
QTRX earnings call for the period ending March 31, 2020.
QTRX earnings call for the period ending December 31, 2019.
QTRX earnings call for the period ending September 30, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
